Professionals 69 results
Capabilities 26 results
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Practice Area
Government Investigations, Enforcement & Compliance
Experience 1 result
Insights & News 137 results
Investigations, Enforcement, & Compliance Alerts
|March 20, 2025
|10+ Min Read
On March 14, 2025, in a late Friday decision, a panel of judges from the U.S. Court of Appeals for the Fourth Circuit ruled that, for the time being, the Trump Administration is permitted to enforce Executive Orders (EOs) 14151 (Ending Radical and Wasteful Government DEI Programs and Preferencing) and 14173 (Ending Illegal Discrimination and Restoring Merit-Based Opportunity), which prohibit Diversity, Equity, and Inclusion (DEI) (also referred to as Diversity, Equity, Inclusion, and Accessibility, or DEIA in the EOs) efforts within the federal government and by federal contractors, respectively.
Government Program Fraud, False Claims Act & Qui Tam Litigation Playbook
|March 13, 2025
|6 Min Read
On February 18, 2025, the United States Court of Appeals for the First Circuit issued its decision in United States v. Regeneron Pharmaceuticals, Inc. adopting the more stringent “but for” causation standard for alleged violations of the False Claims Act (FCA) based on violations of the Anti-Kickback Statute (AKS).
Client Alert
|March 5, 2025
|5 Min Read
Current Status of White House Executive Order on Gender-Affirming Care
On March 4, 2025, in response to a lawsuit by several civil rights organizations and individuals against the federal government’s policy directives on gender-affirming care, a federal court issued a partial block of Executive Order 14187 titled “Protecting Children from Chemical and Surgical Mutilation” and Executive Order 14168 titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government.”
Other Results 14 results
Site Content
Site Content